By Tess Stynes Biogen Idec Inc. (BIIB) said its treatment for hemophilia B, a rare inherited disorder that impairs blood coagulation, showed...
Biogen Idec Inc.'s (BIIB) second-quarter earnings fell 1.8% on acquisition-related and other charges. The biotechnology company's adjusted profit...
Swedish investment company Investor AB (INVE-B.SK) Tuesday said net asset value per share as of June 30 rose 3.6% to SEK231 from the previous...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads